Reduced NOV/CCN3 expression limits inflammation and interstitial renal fibrosis after obstructive nephropathy in mice

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Marchal, Pierre Olivier ^a,b,c   Kavvadas, Panagiotis ^b   Abed, Ahmed ^b,c   Kazazian, Chantal ^a   Authier, Florence ^b   Koseki, Haruhiko ^d   Hiraoka, Shuichi ^e   Boffa, Jean Jacques ^b   Martinerie, Cécile ^a,c   Chadjichristos, Christos E ^b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL TENON   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

^e KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NOV PROTEIN, HUMAN; NOV PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; URETHRA OBSTRUCTION; ANIMAL; BLOOD; C57BL MOUSE; CHRONIC KIDNEY FAILURE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; URETER OBSTRUCTION;

ANIMALS; BIOMARKERS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEPHRITIS, INTERSTITIAL; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RENAL INSUFFICIENCY, CHRONIC; URETERAL OBSTRUCTION;

EID: 84947556927     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137876     Document Type: Article

References (33)

1. Meguid El Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365: 331-340. PMID: 15664230
2. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC (1994) Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266: F926-933. PMID: 7517644
3. Misseri R, Meldrum KK (2005) Mediators of fibrosis and apoptosis in obstructive uropathies. Curr Urol Rep 6: 140-145. PMID: 15717973
4. Silverstein DM, Travis BR, Thornhill BA, Schurr JS, Kolls JK, Leung JC et al. (2003) Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int 64: 25-35. PMID: 12787392
5. Esteban V, Ruperez M, Vita JR, Lopez ES, Mezzano S, Plaza JJ et al. (2003) Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int Suppl: S33-38.
6. Lan HY (2011) Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 7: 1056-1067. PMID: 21927575
7. Ruster C, Wolf G (2011) Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 22: 1189-1199. doi: 10.1681/ASN.2010040384 PMID: 21719784
8. Chen CC, Lau LF (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41: 771-783. doi: 10.1016/j.biocel.2008.07.025 PMID: 18775791
9. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C (2011) The CCN family: A new class of inflammation modulators? Biochimie 93: 377-388 Epub 2010 Dec 2012. doi: 10.1016/j.biochi.2010.11.010 PMID: 21130134
10. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119: 4803-4810. PMID: 17130294
11. Lin C, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY et al. (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278: 24200-24208. PMID: 12695522
12. Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S et al. (2007) Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J Clin Endocrinol Metab 92: 3253-3260. PMID: 17566092
13. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN et al. (1998) nov H: Differential expression in developing kidney and in Wilms' tumors. Am J Pathol 152: 1563-1575. PMID: 9626060
14. Kocialkowski S, Yeger H, Kingdom J, Perbal B, Schofield PN (2001) Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl) 203: 417-427.
15. Bariety J, Mandet C, Hill GS, Bruneval P (2006) Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17: 2770-2780. PMID: 16943305
16. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J et al. (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12: 10-21. PMID: 1309586
17. Martinerie C, Huff V, Joubert I, Badzioch M, Saunders G, Strong L et al. (1994) Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene 9: 2729-2732. PMID: 7520150
18. Niu Z, Ito M, Awakura Y, Takahashi T, Nakamura E, Ito N et al. (2005) The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. J Urol 174: 1460-1462. PMID: 16145471
19. Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML et al. (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174: 1725-1734. doi: 10.2353/ajpath.2009.080241 PMID: 19359517
20. van Roeyen CR, Boor P, Borkham-Kamphorst E, Rong S, Kunter U, Martin IV et al. (2012) A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects. Am J Pathol 180: 1979-1990. doi: 10.1016/j.ajpath.2012.01.031 PMID: 22538190
21. Lafont J, Thibout H, Dubois C, Laurent M, Martinerie C (2005) NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival. Cell Commun Adhes 12: 41-57. PMID: 16371345
22. Abed A, Toubas J, Kavvadas P, Authier F, Cathelin D, Alfieri C et al. (2014) Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice. Kidney Int. 86:768-79. doi: 10.1038/ki.2014.108 PMID: 24850151
23. Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C et al. (2012) Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J 26: 4079-4091. doi: 10.1096/fj.11-194902 PMID: 22751008
24. Le Dreau G, Nicot A, Benard M, Thibout H, Vaudry D, Martinerie C et al. (2010) NOV/CCN3 promotes maturation of cerebellar granule neuron precursors. Mol Cell Neurosci. 1:60-71
25. Calhabeu F, Lafont J, Le Dreau G, Laurent M, Kazazian C, Schaeffer L et al. (2006) NOV/CCN3 impairs muscle cell commitment and differentiation. Exp Cell Res: 1876-1889. PMID: 16600215
26. Pfaffl MW(2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. PMID: 11328886
27. Thibout H, Martinerie C, Creminon C, Godeau F, Boudou P, Le Bouc Y et al. (2003) Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab 88: 327-336. PMID: 12519873
28. Le Dreau G, Kular L, Nicot AB, Calmel C, Melik-Parsadaniantz S, Kitabgi P et al. (2010) NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins. Glia 58: 1510-1521. doi: 10.1002/glia.21025 PMID: 20648642
29. Guerrot D, Kerroch M, Placier S, Vandermeersch S, Trivin C, Mael-Ainin M et al. (2011) Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol 179: 83-91. doi: 10.1016/j.ajpath.2011.03.023 PMID: 21640971
30. Chevalier RL, Forbes MS, Thornhill BA (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75(11):1145-52. doi: 10.1038/ki.2009.86 PMID: 19340094
31. Lin Z, Natesan V, Shi H, Hamik A, Kawanami D, Hao C et al. (2010) A novel role of CCN3 in regulating endothelial inflammation. J Cell Commun Signal 4: 141-153. doi: 10.1007/s12079-010-0095-x PMID: 21063504
32. Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R (2012) Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int 32: 1342-1353. doi: 10.1111/j.1478-3231.2012.02837.x PMID: 22698069
33. Pakradouni J, Le Goff W, Calmel C, Antoine B, Villard E, Frisdal E et al. (2013) Plasma NOV/CCN3 Levels are Closely Associated with Obesity in Patients with Metabolic Disorders. PLoS One 8:e66788. doi: 10.1371/journal.pone.0066788 PMID: 23785511